Figuring out which genes are active and which aren’t – in, say, an organ or a group of cells – is critical for both basic biological research and the development of treatments for diseases like cancer. Researchers at the University of Texas Southwestern Medical Center have developed a way to simultaneously assess, for a given biological sample, the activity of all the genes in the genome, based on how tightly their DNA is wound. DNA spends much of its time coiled up; when a gene is turned on, its segment of the coil unwinds. Biophysicist Harold Garner says he has devised a way to separate coiled DNA from DNA that’s “loose and free.” His team then uses DNA microarrays to determine which genes are in the open group – and therefore active. The technique could help uncover the secrets of a host of diseases, Garner says. The researchers, for instance, are using it to find out how cancer drugs affect gene activity. “This will allow us to hopefully tune some of those drugs and identify new drugs that may work better,” Garner says.
The big new idea for making self-driving cars that can go anywhere
The mainstream approach to driverless cars is slow and difficult. These startups think going all-in on AI will get there faster.
Inside Charm Industrial’s big bet on corn stalks for carbon removal
The startup used plant matter and bio-oil to sequester thousands of tons of carbon. The question now is how reliable, scalable, and economical this approach will prove.
The dark secret behind those cute AI-generated animal images
Google Brain has revealed its own image-making AI, called Imagen. But don't expect to see anything that isn't wholesome.
The hype around DeepMind’s new AI model misses what’s actually cool about it
Some worry that the chatter about these tools is doing the whole field a disservice.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.